Spatial Omics Solutions : Market Share , Size, Types, Regions and Applications Research Report , Prominent Players, Key Developments and Market Segmentations Forecast by 2031

According to the latest research by InsightAce Analytic, The Spatial Omics Solutions Market Size is estimated to be USD 276.5 Million in 2023 and is expected to increase to USD 671.59 Million by 2031, with a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2024-2031.

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1352

The term "spatial omics" denotes a collection of technologies enabling the superimposition of -omics data onto tissue images. Several distinct categories of omics studies are collectively called "omics." For instance, genomics analyzes the entire genome, transcriptomics scans RNA, and proteomics investigates protein content. The primary sequence of genes has been decoded, and the spatial phenotyping method is now used to evaluate the position and interaction of cell types and biomarkers (specifically, DNA/RNA/Protein). Spatial phenotyping systems can be effortlessly integrated into next-generation sequencing (NGS) methodologies.

Consequently, research is increasingly being conducted using innovative devices to progress from the discovery to the translational and clinical stages. The discipline of omics-based analysis has made significant progress. Spatial-omics solution developers are exerting significant effort to expand the reach of their distinctive technologies to a diverse array of clients, such as academic research centres, research institutions, and biopharmaceutical companies. This has led to their efforts to incorporate more intricate features into their products. The following features are included: automated sample processing, biomarker-specific gene panels, high-multiplexing, and image analysis based on machine learning.

Advancements in sequencing technology on a global scale, the increasing prevalence of various types of genetic disorders, and an increase in funding for spatial omics research are all factors pushing the market. This innovative method provides a unique opportunity to gain a more comprehensive understanding of the mechanisms that regulate the specific cell interactions at the tumour boundary, which is highly beneficial in the early detection of malignancy. Furthermore, the market's expansion will be facilitated by the escalation of research into the potential of spatial OMICS as a cancer diagnosis instrument. This will be attributed to the introduction of new advanced devices by medical device manufacturers. The market revenue growth over the forecast period is also anticipated to be driven by the increasing use of spatial genomics and transcriptomics for drug development and biomarker identification.

Enquiry For Before Buying @ https://www.insightaceanalytic.com/enquiry-before-buying/1352

Nevertheless, the absence of computational analytical instruments and the substantial capital investment required for international expansion are two market constraints. Furthermore, a sluggish technological advancement may impede the market's expansion for spatial omics solutions.
North America currently holds the highest portion of the global market for spatial omics solutions due to improvements in healthcare infrastructure, rises in per capita income, and advanced research institutes and laboratories.

The prominent and exclusive market player list includes

• Molecular Machines & Industries (MMI)
• Dovetail Genomics
• Vizgen Corp.
• Optical Biosystems, Inc.
• NanoString Technologies, Inc.
• Bio-Techne Corporation
• Flagship Biosciences, Inc
• Akoya Biosciences, Inc.
• Rebus Biosystems
• BioSpyder Technologies
• Visikol, Inc.
• Illumina Inc.
• Bio-Rad Laboratories, Inc.
• Fluidigm Corporation
• Genomic Vision
• Seven Bridges Genomics
• Resolve Biosciences
• S2 Genomics, Inc.
• Fluidigm Corporation
• 10x Genomics, Inc.
• Bruker
• Canopy Biosciences
• IONpath, Inc.
• Miltenyi Biotec
• RareCyte, Inc.
• Readcoor, Inc.
• Lunaphore Technologies
• Ultivue, Inc.
• Cytiva

Purchase This Premium Report @ https://www.insightaceanalytic.com/buy-report/1352

Key developments in the market

• In June 2022, Vizgen at AGBT demonstrated the expansion of the MERSCOPETM In Situ Single-Cell Spatial Genomics Platform. Two of the company's most recent announcements involve the release of FFPE Human Immuno-oncology data and the expansion of its product plan. It will be possible to develop new applications and increase the flexibility of sample entry through product enhancements from Vizgen.

• In June 2021, Akoya Biosciences, Inc. and AstraZeneca reached an agreement to collaborate on the development of new multiplex immunofluorescence (MIF) workflows and spatial biomarker signatures using Akoya's PhenopticsTM platform. AstraZeneca's immuno-oncology division had collaborated with Advanced Biopharma Solutions (ABS), a premium service offering from Akoya, to capitalize on the PhenopticsTM platform's comprehensive spatial phenotyping capabilities. This will enable them to investigate the mechanisms of action of drugs, verify the prevalence of target biology, and identify predictive signatures for future trial designs.

• In October 2020, 10x Genomics acquired ReadCoor and Cartana, two companies that specialize in the development of in situ analytical technology. Cartana is responsible for the development of in situ RNA analysis technology, while ReadCoor has an RC2 spatial multiomics platform that is based on fluorescence in situ sequencing. In a statement, 10x Genomics stated that the agreements grant it dominion over more than 110 patents.

• In Oct 2020, Bruker Corporation announced the launch of the Vutara VXL Super-Resolution Fluorescence Microscope, which was created for nanoscale biological imaging. With the aid of this innovative system, complex spatial biology research in the areas of virology, neuroscience, and live-cell imaging, as well as extracellular matrix structures and extracellular vesicles, can be carried out (EV).

Market Segmentation:

Global Spatial Omics Solutions Market, by Solution Type
• Services
• Instruments
• Consumables

Global Spatial Omics Solutions Market, by Sample Analyzed
• Protein
• DNA
• RNA

Global Spatial Omics Solutions Market, by Application
• cell biology
• Other Applications
• Translation Research
• Diagnostics
• Drug Discovery and Development
• Single Cell Analysis

Global Spatial Omics Solutions Market, by End-User
• Contract Research Organization
• Academic and Research Institutions
• Biopharmaceutical and Biotechnological Companies
• Other End Users

For Customization this report @ https://www.insightaceanalytic.com/customisation/1352

Global Spatial Omics Solutions Market, by Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Spatial Omics Solutions Market, by Country
• U.S.
• Canada

Europe Spatial Omics Solutions Market, by Country
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Spatial Omics Solutions Market, by Country
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Spatial Omics Solutions Market, by Country
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Spatial Omics Solutions Market, by Country
• GCC Countries
• South Africa
• Rest of Middle East & Africa

View Full Report This Market Insight @ https://www.insightaceanalytic.com/report/global-spatial-omics-solutions-market/1352

Contact Us:

InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis of key market insights in a timely and cost-effective manner.

This release was published on openPR.